Medicare Enrolled
Dr. Ingrid Trenkle, MD
Optician · Redlands, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Trenkle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trenkle?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Trenkle
Dr. Ingrid Trenkle is an optician specialist in Redlands, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Trenkle performed 26,959 Medicare services across 3,683 unique beneficiaries.
Between the years covered by Open Payments, Dr. Trenkle received a total of $51,119 from 53 pharmaceutical and/or device companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Trenkle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in CA
$51,119 industry payments
Medicare Practice Summary
Medicare Utilization ↗26,959
Medicare services
Top 4% in CA for optician
3,683
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,419 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Photodynamic therapy gel for precancerous skin | 20,000 | $1 | $2 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,859 | $5 | $25 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,026 | $40 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
692 | $63 | $100 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
656 | $82 | $125 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
656 | $29 | $50 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
619 | $37 | $100 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
155 | $91 | $175 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
146 | $36 | $55 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
132 | $67 | $140 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
126 | $130 | $225 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
126 | $1 | $10 |
| Destruction of skin growth, 15 or more growths | 119 | $104 | $200 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
115 | $47 | $125 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
100 | $217 | $325 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
76 | $73 | $150 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 54 | $347 | $650 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
51 | $525 | $800 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
43 | $42 | $75 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
34 | $243 | $325 |
| Skin growth removal and lab exam, 1-5 blocks A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination. |
31 | $510 | $700 |
| Skin cancer growth removal, 0.6-1.0 cm This procedure involves the surgical removal of a cancerous skin growth located on the body, arms, or legs. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
28 | $96 | $300 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
24 | $49 | $86 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
22 | $139 | $200 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
20 | $2 | $10 |
| Additional Mohs surgery stage with microscopic exam This procedure involves the removal and microscopic examination of an additional stage of tissue from the trunk, arms, or legs. It is performed in stages to ensure complete removal of the growth. |
19 | $333 | $500 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $97 | $125 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
12 | $66 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
2.4% medium
97.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$51,119
Total received (2018-2024)
Avg $7,303/year across 7 years
Top 5% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
762
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20,467 (40.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,226 (37.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,426 (22.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,777
2023
$3,220
2022
$6,057
2021
$1,997
2020
$1,324
2019
$9,270
2018
$24,475
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
REVANCE THERAPEUTICS, INC.
$579
LEO Pharma Inc.
$446
ABBVIE INC.
$406
PFIZER INC.
$404
Dermavant Sciences, Inc.
$355
Galderma Laboratories, L.P.
$316
E.R. Squibb & Sons, L.L.C.
$247
Lilly USA, LLC
$241
Arcutis Biotherapeutics, Inc.
$195
Regeneron Healthcare Solutions, Inc.
$190
Biofrontera Inc.
$169
Amgen Inc.
$148
Paratek Pharmaceuticals, Inc.
$134
GENZYME CORPORATION
$130
Journey Medical Corporation
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$121
Janssen Biotech, Inc.
$115
MAYNE PHARMA COMMERCIAL LLC
$86
SUN PHARMACEUTICAL INDUSTRIES INC.
$76
Almirall LLC
$53
Mallinckrodt Hospital Products Inc.
$49
Novartis Pharmaceuticals Corporation
$47
Incyte Corporation
$45
UCB, Inc.
$23
Verrica Pharmaceuticals Inc.
$21
Ortho Dermatologics, a division of Bausch Health US, LLC
$20
Solta Medical, a division of Bausch Health US, LLC
$18
Organogenesis Inc.
$16
Top 3 companies account for 29.9% of 2024 payments
All-time payments by company (2018-2024) ›
Galderma Laboratories, L.P.
$16,821
LEO Pharma Inc.
$13,709
PFIZER INC.
$4,437
Biofrontera Inc.
$2,196
GENZYME CORPORATION
$1,142
AbbVie Inc.
$992
Lilly USA, LLC
$928
Amgen Inc.
$900
Regeneron Healthcare Solutions, Inc.
$818
ABBVIE INC.
$801
Novartis Pharmaceuticals Corporation
$723
Almirall LLC
$692
Dermavant Sciences, Inc.
$587
REVANCE THERAPEUTICS, INC.
$579
EPI Health, LLC
$493
Paratek Pharmaceuticals, Inc.
$381
AbbVie, Inc.
$375
Celgene Corporation
$358
E.R. Squibb & Sons, L.L.C.
$341
UCB, Inc.
$273
Incyte Corporation
$263
Sun Pharmaceutical Industries Inc.
$260
SUN PHARMACEUTICAL INDUSTRIES INC.
$241
Arcutis Biotherapeutics, Inc.
$233
SANOFI-AVENTIS U.S. LLC
$230
Allergan Inc.
$216
Janssen Biotech, Inc.
$196
Ortho Dermatologics, a division of Bausch Health US, LLC
$181
MAYNE PHARMA COMMERCIAL LLC
$177
Journey Medical Corporation
$172
Mayne Pharma Inc.
$167
VYNE Pharmaceuticals Inc.
$156
Genentech USA, Inc.
$133
Boehringer Ingelheim Pharmaceuticals, Inc.
$121
Lumenis, Inc
$103
MAYNE PHARMA INC.
$88
Merz North America, Inc.
$86
Bayer HealthCare Pharmaceuticals Inc.
$76
NOVARTIS PHARMACEUTICALS CORPORATION
$57
Allergan, Inc.
$55
AcelRx Pharmaceuticals, Inc.
$52
Mallinckrodt Hospital Products Inc.
$49
Nabriva Therapeutics, plc
$49
STRATA Skin Sciences, Inc.
$30
Smith+Nephew, Inc.
$30
Merck Sharp & Dohme Corporation
$30
PruGen, Inc. Pharmaceuticals
$24
Verrica Pharmaceuticals Inc.
$21
Solta Medical, a division of Bausch Health US, LLC
$18
Organogenesis Inc.
$16
Sandoz Inc.
$16
Novum Pharma, LLC
$15
Mylan Pharmaceuticals Inc.
$11
Top 3 companies account for 68.4% of all-time payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA LD · ACTHAR · ADBRY · AKLIEF · AMELUZ · APEXICON E · ARAZLO · Absorica LD · Aczone · Alcortin A · Ameluz · BOTOX · BOTOX COSMETIC · Bimzelx · CIBINQO · CLEAR+BRILLIANT · CLODERM · COSENTYX · Cimzia · DAXXIFY · DERMATITIS - DISEASE · DORYX · DSUVIA · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Erivedge · FINACEA · Finacea · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · Klisyri · LIBTAYO · LITFULO · Lumenis Pulse 120H · NUZYRA · OLUMIANT · OPZELURA · ORACEA · Oasis · Olux · Otezla · PICATO · QBREXZA · REMICADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sivextro · Sotyktu · TALTZ · TREMFYA · TRI-LUMA · TRILUMA · TargaDox · VTAMA · Winlevi · XEOMIN · XTRAC · Xolegel · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (40%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for optician in CA.
Geographic Context
Opticians within 10 mi
192
Per 100K population
8.8
County median income
$82,184
Nearest hospital
REDLANDS COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Trenkle is a mixed practice specialist, with above-average Medicare volume (top 4% in CA), with mixed engagement industry engagement in the top 5% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Trenkle experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Trenkle performed 20,000 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Trenkle receive payments from pharmaceutical companies?
Yes. Dr. Trenkle received a total of $51,119 from 53 companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Trenkle's costs compare to other opticians in Redlands?
Dr. Trenkle's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Trenkle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Redlands
Browse opticians in Redlands ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
LEO Pharma Inc. Payments to Doctors
See all physicians who received payments from LEO Pharma Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology